Proposed Data Collections Submitted for Public Comment and Recommendations, 66069-66070 [2011-27588]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 206 / Tuesday, October 25, 2011 / Notices
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than November 18,
2011.
A. Federal Reserve Bank of Atlanta
(Chapelle Davis, Assistant Vice
President) 1000 Peachtree Street, NE.,
Atlanta, Georgia 30309:
1. BankUnited, Inc., Miami Lakes,
Florida; to become a bank holding
company by acquiring 100 percent of
the voting shares of BankUnited,
National Association, Miami Lakes,
Florida, upon the conversion of its
subsidiary Bank United, a federal
savings bank, to a national bank.
Board of Governors of the Federal
Reserve System, October 20, 2011.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 2011–27534 Filed 10–24–11; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–12–12AG]
sroberts on DSK5SPTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Catina Conner, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
HIV Prevention Among Latino MSM:
Evaluation of a Locally Developed
Intervention—New—National Center for
HIV/AIDS, Viral Hepatitis, STD, TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Latinos are the largest and fastest
growing ethnic minority group in the
U.S. and have the second highest rate of
HIV/AIDS diagnoses of all racial/ethnic
groups in the country. From the
beginning of the epidemic through 2007,
Latinos accounted for 17% of all AIDS
cases reported to the CDC. Among
Latino males, male-to-male sexual
contact is the single most important
source of HIV infection, accounting for
46% of HIV infections in U.S.-born
Latino men from 2001 to 2005, and for
more than one-half of HIV infections
among South American, Cuban, and
Mexican-born Latino men in the U.S.
(CDC, 2007a; 2007b). In 2006, male-tomale sex accounted for 72% of new HIV
infections among Latino males. Relative
to other men who have sex with men
(MSM), the rate of HIV infection among
Latino MSM is twice the rate recorded
among whites (43.1 vs. 19.6 per
100,000).
Despite the high levels of infection
risk that affect Latino MSM, no
efficacious interventions to prevent
infection by HIV and other sexually
transmitted diseases (STDs) are
available for this vulnerable population.
CDC’s Prevention Research Synthesis
group, whose role is to identify HIV
prevention interventions that have met
rigorous criteria for demonstrating
evidence of efficacy, has not identified
Number of
respondents
Type of respondent
Form name
Prospective Study Participant ......
Participant Screening Form ........
VerDate Mar<15>2010
18:10 Oct 24, 2011
Jkt 226001
PO 00000
Frm 00038
Fmt 4703
any behavioral interventions for Latino
MSM that meet current efficacy criteria,
and no such interventions are listed in
CDC’s 2011 update of its Compendium
of Evidence-Based HIV Behavioral
Interventions (https://www.cdc.gov/hiv/
topics/research/prs/compendiumevidence-based-interventions.htm).
There is an urgent need for efficacious,
culturally congruent HIV/STD
prevention interventions for Latino
MSM.
The purpose of this project is to test
the efficacy of an HIV prevention
intervention for reducing sexual risk
among Latino men who have sex with
men in North Carolina. The HOLA en
Grupos intervention is a Spanishlanguage, small-group, 4-session
intervention that is designed to increase
consistent and correct condom use and
HIV testing among Latino MSM and to
affect other behavioral and psychosocial
factors that can increase their
vulnerability of HIV/STD infection. This
study will use a randomized controlled
trial design to assess the efficacy of the
HOLA en Grupos intervention
compared to a general health
comparison intervention.
CDC is requesting approval for a 3year clearance for data collection. The
data collection system involves
screening of potential study participants
for eligibility, collection of participants’
contact information, and measures of
intervention and comparison
participants’ socio-demographic
characteristics, health seeking actions,
HIV/STD and substance use-related risk
behaviors, and psychosocial factors at
baseline before intervention delivery
and 6 months after intervention
delivery. An estimated 350 men will be
screened for eligibility in order to enroll
the 300 men required for the study. The
baseline and the 6-month follow-up
assessments will be similar. However,
the 6-month assessment will ask study
participants fewer questions because
there is no need to ask all questions
during both assessments. Collection of
eligibility information from potential
participants will require about 10
minutes; collection of baseline
assessment information and participant
contact information will require about 1
hour and 45 minutes; and collection of
the 6-month follow-up assessment
information will require about 1 hour.
There is no cost to participants other
than their time.
Number
responses per
respondent
350
Sfmt 4703
66069
E:\FR\FM\25OCN1.SGM
Average burden
per respondent
(in hours)
1
25OCN1
10/60
Total annual
burden in
hours
58
66070
Federal Register / Vol. 76, No. 206 / Tuesday, October 25, 2011 / Notices
Number of
respondents
Number
responses per
respondent
Average burden
per respondent
(in hours)
Total annual
burden in
hours
Type of respondent
Form name
Enrolled Study Participant ...........
Enrolled Study Participant ...........
Baseline Assessment ..................
6-month follow-up assessment ...
300
300
1
1
1.75
1
525
300
Total .............................................
......................................................
..........................
..........................
............................
883
Catina Conner,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2011–27588 Filed 10–24–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–12–0800]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Focus Group Testing to Effectively
Plan and Tailor Cancer Prevention and
Control Communication Campaigns
(OMB No. 0920–0800, exp. 1/31/2012)—
Extension (Generic)—National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The mission of the CDC’s Division of
Cancer Prevention and Control (DCPC)
is to reduce the burden of cancer in the
United States through cancer
prevention, reduction of risk, early
detection, better treatment, and
improved quality of life for cancer
survivors. Toward this end, the DCPC
supports the scientific development,
implementation, and evaluation of
various health communication
campaigns with an emphasis on specific
cancer burdens. This process requires
testing of messages, concepts, and
materials prior to their final
development and dissemination.
Communication campaigns vary
according to the type of cancer, the
qualitative dimensions of the message
described above, and the type of
respondents.
CDC is requesting OMB approval of a
three-year extension to an existing
generic clearance that supports cancerrelated communications (OMB No.
0920–0800, exp. 1/31/2012).
Information will be collected primarily
through focus groups, and will be used
to assess numerous qualitative
dimensions of cancer prevention and
control messages, including, but not
limited to, knowledge, attitudes, beliefs,
behavioral intentions, information
needs and sources, and compliance to
recommended screening intervals.
Insights gained from the focus groups
will assist in the development and/or
refinement of future campaign messages
and materials.
Over a three-year period, DCPC plans
to conduct or sponsor up to 72 focus
groups per year, with each group
involving an average of 12 respondents.
Screening will be conducted to recruit
respondents for specific target
audiences, e.g., health care providers or
the general public. Each focus group
discussion will be facilitated by a
written discussion guide, and will last
approximately two hours. CDC will
submit an information collection
request to OMB for approval of each
focus group activity.
There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
1,814.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Health care providers and general public .......
Screening Form ..............................................
Focus Group Discussion Guide .....................
Dated: October 18, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sroberts on DSK5SPTVN1PROD with NOTICES
[FR Doc. 2011–27586 Filed 10–24–11; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
[30-Day–12–0278]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
VerDate Mar<15>2010
18:10 Oct 24, 2011
Jkt 226001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
1,728
864
Number of
responses
per
respondent
Average
burden per
response
(in hours)
1
1
3/60
2
review by the Office of Management and
Budget (OMB) in compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995.
To request a copy of these requirements,
call the CDC Reports Clearance Officer
at (404) 639–5960 or send an e-mail to
omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 76, Number 206 (Tuesday, October 25, 2011)]
[Notices]
[Pages 66069-66070]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27588]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-12-12AG]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Catina Conner, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
HIV Prevention Among Latino MSM: Evaluation of a Locally Developed
Intervention--New--National Center for HIV/AIDS, Viral Hepatitis, STD,
TB Prevention (NCHHSTP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Latinos are the largest and fastest growing ethnic minority group
in the U.S. and have the second highest rate of HIV/AIDS diagnoses of
all racial/ethnic groups in the country. From the beginning of the
epidemic through 2007, Latinos accounted for 17% of all AIDS cases
reported to the CDC. Among Latino males, male-to-male sexual contact is
the single most important source of HIV infection, accounting for 46%
of HIV infections in U.S.-born Latino men from 2001 to 2005, and for
more than one-half of HIV infections among South American, Cuban, and
Mexican-born Latino men in the U.S. (CDC, 2007a; 2007b). In 2006, male-
to-male sex accounted for 72% of new HIV infections among Latino males.
Relative to other men who have sex with men (MSM), the rate of HIV
infection among Latino MSM is twice the rate recorded among whites
(43.1 vs. 19.6 per 100,000).
Despite the high levels of infection risk that affect Latino MSM,
no efficacious interventions to prevent infection by HIV and other
sexually transmitted diseases (STDs) are available for this vulnerable
population. CDC's Prevention Research Synthesis group, whose role is to
identify HIV prevention interventions that have met rigorous criteria
for demonstrating evidence of efficacy, has not identified any
behavioral interventions for Latino MSM that meet current efficacy
criteria, and no such interventions are listed in CDC's 2011 update of
its Compendium of Evidence-Based HIV Behavioral Interventions (https://www.cdc.gov/hiv/topics/research/prs/compendium-evidence-based-interventions.htm). There is an urgent need for efficacious, culturally
congruent HIV/STD prevention interventions for Latino MSM.
The purpose of this project is to test the efficacy of an HIV
prevention intervention for reducing sexual risk among Latino men who
have sex with men in North Carolina. The HOLA en Grupos intervention is
a Spanish-language, small-group, 4-session intervention that is
designed to increase consistent and correct condom use and HIV testing
among Latino MSM and to affect other behavioral and psychosocial
factors that can increase their vulnerability of HIV/STD infection.
This study will use a randomized controlled trial design to assess the
efficacy of the HOLA en Grupos intervention compared to a general
health comparison intervention.
CDC is requesting approval for a 3-year clearance for data
collection. The data collection system involves screening of potential
study participants for eligibility, collection of participants' contact
information, and measures of intervention and comparison participants'
socio-demographic characteristics, health seeking actions, HIV/STD and
substance use-related risk behaviors, and psychosocial factors at
baseline before intervention delivery and 6 months after intervention
delivery. An estimated 350 men will be screened for eligibility in
order to enroll the 300 men required for the study. The baseline and
the 6-month follow-up assessments will be similar. However, the 6-month
assessment will ask study participants fewer questions because there is
no need to ask all questions during both assessments. Collection of
eligibility information from potential participants will require about
10 minutes; collection of baseline assessment information and
participant contact information will require about 1 hour and 45
minutes; and collection of the 6-month follow-up assessment information
will require about 1 hour.
There is no cost to participants other than their time.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number Average burden Total annual
Type of respondent Form name Number of responses per per respondent burden in
respondents respondent (in hours) hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Prospective Study Participant.................. Participant Screening Form........ 350 1 10/60 58
[[Page 66070]]
Enrolled Study Participant..................... Baseline Assessment............... 300 1 1.75 525
Enrolled Study Participant..................... 6-month follow-up assessment...... 300 1 1 300
--------------------------------------------------------------------
Total.......................................... .................................. ............... ............... ................ 883
--------------------------------------------------------------------------------------------------------------------------------------------------------
Catina Conner,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2011-27588 Filed 10-24-11; 8:45 am]
BILLING CODE 4163-18-P
